Skip to content

Sellalax

by Laboratorio Chimico Farmaceutico A. Sella Srl Italy EUDAMED

Ref 05614Model SUPPOSTE GLICEROLO SELLA

EMDN G99

Regulatory status

as of 24 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDD NumberB-08032632600503E4 Basic UDI-DIDate25 May 2023RegisteredStatusActive

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Expiring (legacy directive)
  • Not covered

European Union — CE/MDD Expiring (legacy directive)

Certificates: none listed in EUDAMED

Specification

EUDAMED · synced 22 Oct 2026

Model / Reference
SUPPOSTE GLICEROLO SELLA, 05614
Primary DI / UDI-DI
D-08032632600503E4
Basic UDI-DI
B-08032632600503E4
EMDN Code
G99 Gastrointestinal devices - other
Device Class
Class I
Market of Registration
Italy

Manufacturer details

EUDAMED SRN
IT-MF-000026481

Other devices from Laboratorio Chimico Farmaceutico A. Sella Srl

See all devices from Laboratorio Chimico Farmaceutico A. Sella Srl →

Properties & raw data

Show properties, registry sources and raw records
Other properties (11)
  • Sterile: No
  • Implantable: No
  • Reusable: No
  • Contains Latex: No
  • Reprocessed: No
  • Human-derived: No
  • Human Tissues: No
  • Animal Tissues: No
  • Administering Medicine: No
  • Measuring Function: No
  • Incorporates Medicinal Product: No

Sources (1)

  • EUDAMED a63bb80e-cf36-42f8-ba73-cfc4e1c4223f 61 fields · synced 22 Oct 2026